Taiwan · Delayed Price · Currency is TWD Bioteque Statistics
Total Valuation
Bioteque has a market cap or net worth of TWD 8.00 billion. The enterprise value is 6.74 billion.
| Market Cap | 8.00B |
| Enterprise Value | 6.74B |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | Jul 28, 2026 |
Share Statistics
Bioteque has 69.30 million shares outstanding. The number of shares has increased by 0.11% in one year.
| Current Share Class | 69.30M |
| Shares Outstanding | 69.30M |
| Shares Change (YoY) | +0.11% |
| Shares Change (QoQ) | -0.54% |
| Owned by Insiders (%) | 4.22% |
| Owned by Institutions (%) | 6.01% |
| Float | 47.62M |
Valuation Ratios
The trailing PE ratio is 14.64.
| PE Ratio | 14.64 |
| Forward PE | n/a |
| PS Ratio | 3.70 |
| PB Ratio | 2.37 |
| P/TBV Ratio | 2.37 |
| P/FCF Ratio | 13.18 |
| P/OCF Ratio | 11.39 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.83, with an EV/FCF ratio of 11.09.
| EV / Earnings | 12.26 |
| EV / Sales | 3.12 |
| EV / EBITDA | 7.83 |
| EV / EBIT | 9.81 |
| EV / FCF | 11.09 |
Financial Position
The company has a current ratio of 2.53, with a Debt / Equity ratio of 0.16.
| Current Ratio | 2.53 |
| Quick Ratio | 2.17 |
| Debt / Equity | 0.16 |
| Debt / EBITDA | 0.62 |
| Debt / FCF | 0.88 |
| Interest Coverage | 94.53 |
Financial Efficiency
Return on equity (ROE) is 16.61% and return on invested capital (ROIC) is 23.60%.
| Return on Equity (ROE) | 16.61% |
| Return on Assets (ROA) | 8.97% |
| Return on Invested Capital (ROIC) | 23.60% |
| Return on Capital Employed (ROCE) | 17.93% |
| Weighted Average Cost of Capital (WACC) | 4.80% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.45 |
| Inventory Turnover | 3.97 |
Taxes
In the past 12 months, Bioteque has paid 138.26 million in taxes.
| Income Tax | 138.26M |
| Effective Tax Rate | 20.10% |
Stock Price Statistics
The stock price has decreased by -0.43% in the last 52 weeks. The beta is 0.14, so Bioteque's price volatility has been lower than the market average.
| Beta (5Y) | 0.14 |
| 52-Week Price Change | -0.43% |
| 50-Day Moving Average | 117.17 |
| 200-Day Moving Average | 119.75 |
| Relative Strength Index (RSI) | 46.78 |
| Average Volume (20 Days) | 111,629 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Bioteque had revenue of TWD 2.16 billion and earned 549.63 million in profits. Earnings per share was 7.89.
| Revenue | 2.16B |
| Gross Profit | 959.27M |
| Operating Income | 687.17M |
| Pretax Income | 687.89M |
| Net Income | 549.63M |
| EBITDA | 843.52M |
| EBIT | 687.17M |
| Earnings Per Share (EPS) | 7.89 |
Balance Sheet
The company has 1.80 billion in cash and 531.96 million in debt, with a net cash position of 1.26 billion or 18.25 per share.
| Cash & Cash Equivalents | 1.80B |
| Total Debt | 531.96M |
| Net Cash | 1.26B |
| Net Cash Per Share | 18.25 |
| Equity (Book Value) | 3.38B |
| Book Value Per Share | 48.77 |
| Working Capital | 1.48B |
Cash Flow
In the last 12 months, operating cash flow was 702.85 million and capital expenditures -95.35 million, giving a free cash flow of 607.49 million.
| Operating Cash Flow | 702.85M |
| Capital Expenditures | -95.35M |
| Depreciation & Amortization | 156.34M |
| Net Borrowing | -188.77M |
| Free Cash Flow | 607.49M |
| FCF Per Share | 8.77 |
Margins
Gross margin is 44.34%, with operating and profit margins of 31.76% and 25.41%.
| Gross Margin | 44.34% |
| Operating Margin | 31.76% |
| Pretax Margin | 31.80% |
| Profit Margin | 25.41% |
| EBITDA Margin | 38.99% |
| EBIT Margin | 31.76% |
| FCF Margin | 28.08% |
Dividends & Yields
This stock pays an annual dividend of 5.50, which amounts to a dividend yield of 4.76%.
| Dividend Per Share | 5.50 |
| Dividend Yield | 4.76% |
| Dividend Growth (YoY) | 10.00% |
| Years of Dividend Growth | 1 |
| Payout Ratio | 63.04% |
| Buyback Yield | -0.11% |
| Shareholder Yield | 4.61% |
| Earnings Yield | 6.87% |
| FCF Yield | 7.59% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on August 20, 2015. It was a reverse split with a ratio of 0.8006917977.
| Last Split Date | Aug 20, 2015 |
| Split Type | Reverse |
| Split Ratio | 0.8006917977 |
Scores
Bioteque has an Altman Z-Score of 5.46 and a Piotroski F-Score of 8.
| Altman Z-Score | 5.46 |
| Piotroski F-Score | 8 |